重大事件
即時報告
8-K
2026-06-05
Grace Therapeutics 提交8-K 披露董事離職及薪酬安排變動
AI 繁中摘要
Grace Therapeutics, Inc.（股票代碼：GRCE）於2026年6月5日向SEC提交了一份8-K表格，報告日期為2026年6月1日。該申報主要涵蓋兩項內容：Item 5.02（董事或特定高管的離職、選舉、任命；部分高管的薪酬安排）及Item 9.01（財務報表及附件）。公司同時提交了附件10.1，推測為相關的薪酬協議或變動文件。
截至目前，申報中未披露具體的財務數字或業績指引。管理層變動或薪酬調整可能影響公司未來的決策方向及穩定度，投資者宜留意後續公告以評估潛在影響。Grace Therapeutics 為一家專注於藥物製劑的生物製藥公司，總部位於新澤西州普林斯頓。
展開英文正文
EDGAR Filing Documents for 0001140361-26-024269 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001140361-26-024269 Filing Date 2026-06-05 Accepted 2026-06-05 16:09:22 Documents 12 Period of Report 2026-06-01 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K ef20075612_8k.htm iXBRL 8-K 32246 2 EXHIBIT 10.1 ef20075612_ex10-1.htm EX-10.1 68530 Complete submission text file 0001140361-26-024269.txt 245456 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA grce-20260601.xsd EX-101.SCH 3859 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grce-20260601_lab.xml EX-101.LAB 21966 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grce-20260601_pre.xml EX-101.PRE 16040 15 EXTRACTED XBRL INSTANCE DOCUMENT ef20075612_8k_htm.xml XML 4232 Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602 Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings) EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331 Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 261069132 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)